Both Hengrui Pharmas ribupatide and Innovents higher-dose mazdutide have reported phase 3 trial data suggesting greater weight-loss efficacy than semaglutide
Because it engages all three, retatrutide is often described as a triple agonist. For comparison, tirzepatide is a dual agonist (GLP-1 and GIP) and semaglutide is a single agonist (GLP-1)
In the STEP 1 trial extension, people regained about two-thirds of their lost weight in the year after stopping suddenly
Efficacy of multi-strain probiotic along with dietary and lifestyle modifications on polycystic ovary syndrome: a randomised, double-blind placebo-controlled study
5 out of every 1,000 patients treated daily with 300 mg canagliflozin, and 3 out of every 1,000 patients treated with placebo
The answer lies in how these medications affect digestion and the risks they pose under anesthesia